M. Wiebe

Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing

Robert J. Ballard, C. Dowd, S. Springs, 2018, PDA Journal of Pharmaceutical Science and Technology.

Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus.

R. Tesh, N. Karabatsos, C. Calisher, 1980, Intervirology.

Viral contamination in biologic manufacture and implications for emerging therapies

David W. Roush, S. Springs, A. Sinskey, 2020, Nature Biotechnology.

Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS).

R. Kiss, J. Goldmann, S. Springs, 2023, Biologicals : journal of the International Association of Biological Standardization.

Revisiting mouse minute virus inactivation by high temperature short time treatment

S. Springs, P. Barone, Jonathan Rice, 2021, Biotechnology and bioengineering.

Viral contamination in biologic manufacture and implications for emerging therapies

David W. Roush, S. Springs, A. Sinskey, 2020, Nature Biotechnology.

Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications.

M. Suthanthiran, M. Wiebe, K. Stenzel, 1987, Kidney international.

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

R. Mertelsmann, K. Welte, C. Nathan, 1984, Journal of Experimental Medicine.

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

C. Nathan, H. Murray, E. Stanley, 1984, The Journal of experimental medicine.

An attenuated mutant of Venezuelan encephalitis virus: biochemical alterations and their genetic association with attenuation.

E. Emini, M. Wiebe, M. Wiebe, 1981, Virology.